Be All EARS, DVAX Gets FDA Date, JAZZ Hits Right Notes, It's A No For OPK

Jazz Pharmaceuticals plc's Defitelio has been approved by the FDA for the treatment of adult and pediatric patients with hepatic veno-occlusive disease, also known as sinusoidal obstruction syndrome, with renal or pulmonary dysfunction following hematopoietic stem-cell transplantation.

from RTT - Biotech http://ift.tt/1SotJLa
via IFTTT